Amneal Pharmaceuticals (AMRX) Granted Second US Biosimilars Approval with ALYMSYS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/17/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
| AmerElite Solutions, Inc. New (NASDAQ: AMRX) | Delayed: 19.18 -0.07 (0.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.25 | 52 Week High | $0.19 | |||
| Open | $19.28 | 52 Week Low | $0.07 | |||
| Day High | $19.39 | P/E | N/A | |||
| Day Low | $18.94 | EPS | $-0.01 | |||
| Volume | 2,429,166 | |||||
